Off-label Use of Recombinant Activated Factor VII for Cardiac Surgical Bleeding

Anesthesiology. 2023 Aug 1;139(2):197-210. doi: 10.1097/ALN.0000000000004569.

Authors

Brigid C Flynn¹, Marie E Steiner², Michael Mazzeffi³

Affiliations

¹ Department of Anesthesiology, University of Kansas Medical Center, Kansas City, Kansas.
² Divisions of Hematology/Oncology and Critical Care, University of Minnesota, Minneapolis, Minnesota.
³ Department of Anesthesiology, University of Virginia School of Medicine, Charlottesville, Virginia.

PMID: 37155359
DOI: 10.1097/ALN.0000000000004569

No abstract available

MeSH terms

Blood Loss, Surgical / prevention & control
Cardiac Surgical Procedures* / adverse effects
Factor VIIa* / therapeutic use
Humans
Off-Label Use
Postoperative Hemorrhage / drug therapy
Recombinant Proteins / therapeutic use
Retrospective Studies

Substances

Factor VIIa
Recombinant Proteins